Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Bailey

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Diabetes, Obesity & Metabolism|July 3, 2019
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3)Timothy S Bailey, Jasmanda Wu, Fang L Zhou, et al.
Diabetes Technology & Therapeutics|August 4, 2015
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyRam Weiss, Satish K Garg, Bruce W Bode, et al.
Journal of Diabetes Science and Technology|October 16, 2013
A new test strip technology platform for self-monitoring of blood glucoseRobert Bernstein, Joan Lee Parkes, Amy Goldy, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world studySean D Sullivan, Charlie J Nicholls, Rishab A Gupta, et al.
Diabetes Technology & Therapeutics|September 13, 2018
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT StudyHalis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, et al.
Diabetes Technology & Therapeutics|February 22, 2017
Evaluation of a Predictive Low-Glucose Management System In-ClinicBruce A Buckingham, Timothy S Bailey, Mark Christiansen, et al.
Diabetes Technology & Therapeutics|January 27, 2025
Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE StudyTimothy S Bailey, David R Liljenquist, Douglas S Denham, et al.
Diabetes Technology & Therapeutics|February 10, 2012
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studySatish Garg, Ronald L Brazg, Timothy S Bailey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 6, 2016
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENTTimothy S Bailey, George Grunberger, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|January 11, 2014
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic studySatish K Garg, Ronald L Brazg, Timothy S Bailey, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|July 3, 2019
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3)Timothy S Bailey, Jasmanda Wu, Fang L Zhou, et al.
Diabetes Technology & Therapeutics|August 4, 2015
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyRam Weiss, Satish K Garg, Bruce W Bode, et al.
Journal of Diabetes Science and Technology|October 16, 2013
A new test strip technology platform for self-monitoring of blood glucoseRobert Bernstein, Joan Lee Parkes, Amy Goldy, et al.
Diabetes, Obesity & Metabolism|May 31, 2019
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world studySean D Sullivan, Charlie J Nicholls, Rishab A Gupta, et al.
Diabetes Technology & Therapeutics|September 13, 2018
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT StudyHalis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, et al.
Diabetes Technology & Therapeutics|February 22, 2017
Evaluation of a Predictive Low-Glucose Management System In-ClinicBruce A Buckingham, Timothy S Bailey, Mark Christiansen, et al.
Diabetes Technology & Therapeutics|January 27, 2025
Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE StudyTimothy S Bailey, David R Liljenquist, Douglas S Denham, et al.
Diabetes Technology & Therapeutics|February 10, 2012
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studySatish Garg, Ronald L Brazg, Timothy S Bailey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 6, 2016
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENTTimothy S Bailey, George Grunberger, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|January 11, 2014
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic studySatish K Garg, Ronald L Brazg, Timothy S Bailey, et al.
Pageof 11